Scientific paper - Ressources

EORTC 2017 – “Anti tumour activity of new antibody drug conjugate (ADC) with eribulin in triple negative breast cancer (TNBC) patient-derived xenograft (PDX)”

Circle Oncodesign Services

Read the poster here

Share:
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.